National ministries and commissions brewing Chinese herbal medicine package support plan
2021-07-02 13:06:14
After experiencing the price of bulls in the past four years, Chinese herbal medicines finally gained the same policy status as other agricultural products.
The reporter was informed that the State Food and Drug Administration, the Administration of Traditional Chinese Medicine and the National Development and Reform Commission and other departments are planning a support package for Chinese herbal medicines, including organizing the cultivation and excavation of Chinese herbal medicines, establishing a new circulation system, and strengthening supervision of sales links. The new plan will follow the country’s partial policy on agricultural products. It mainly considers the supply and demand balance of Chinese herbal medicines, and plans to build an e-commerce platform to encourage pharmaceutical companies and drug farmers to sell point-to-point, and to prevent hot money speculation.
The TCM official told reporters that through careful and meticulous mediation, the state hopes that the interest of the drug, peasants, pharmaceutical companies, and intermediaries on the interest chain will gradually become more balanced. The above new measures will be implemented next year.
The profit of drug farmers tends to thin
SFDA officials told this newspaper that while the price of Chinese herbal medicines has risen in recent years, the labor costs for planting have also risen. It has become an indisputable fact that the profits of drug farmers have become thinner and thinner.
Taking "Safflower" as an example, at present, a kilogram of land can produce 10 kilograms of safflower. The picking fee for a kilogram of safflower needs 60 yuan, the price for selling to middlemen is the highest when it is 83 kilograms per kilogram. It is 23 yuan, which means that the spread for 10 kg is 230 yuan.
But this 230 yuan also includes various expenses. "Before 2000, a kilogram of picking fee was 8 yuan. At that time, it was very easy to find workers. Now that it has risen to 60 yuan, it is still difficult to find workers." According to the introduction of Chen, a farmer and grower, the safflower was matured for four months. From the start of sowing, he asked the picking workers. After contacting the workers, they had to drive to the home to pick them up. After picking the park, they were arranged separately. After eating and staying, after the picking is completed, the workers have to buy a ticket for the return journey. “Before it was the workers who took the initiative to find us, and the tolls were responsible for them. The food and shelter were sometimes self-care for the workers. Now it is people who come to the door asking for work. If they can’t eat well, it’s not enough. Sleeping also requires Simmons mattresses. Workers’ requests can be It was high.†The farmer said that the workers are now unable to afford it. Because, in addition to these costs, there are also utilities for culturing safflower, so it's best to make a profit of 3% more, and sometimes it's done.
It is understood that the cost of planting, excavation, processing, transportation and other aspects of Chinese herbal medicines has been increasing year by year, and the production cost of medicinal materials has been greatly increased. The production cost of Sanqi in Yunnan Province has risen from 10,000 yuan per acre before 2008 to the current level. 30,000 yuan per mu. Picking of safflower, schisandra, wolfberry, etc., hiring costs as high as 80 to 100 yuan a day. In some years, there are situations where safflower and schisandra are not harvested at the time of harvest. “If this situation continues, the farmers will not grow any more. If they are not planted, they will cause panic in the drug market.†Long Xingchao, director of the Chinese Medicine Information Center of the Chinese Medicine Association, told this newspaper.
Price roller coaster
From the 1990s to 2007, domestic prices of Chinese herbal medicines have been unrelenting, and the real fluctuation cycle has started since 2007.
At the beginning of the year, the prices of some domestic production materials and consumer goods continued to rise. In the Chinese herbal medicine market, Angelica first opened up the price increase and led the prices of northwest medicinal herbs such as Codonopsis, Huanghua, Huanghua, Dahuang, and Yinchen. By the second half of the year, the price of most Chinese herbal medicines has been drastically changed and the roller coaster market has appeared.
However, compared to the price trend in the past two years, the 2007 wave of the market is nothing. According to the monitoring data of Chinese herbal medicines, the Taizi ginseng price was only RMB 22.3/kg in January 2007. By June 2011, its price had reached RMB 250/kg, an increase of 1021.08%.
By the end of 2010, of the 537 varieties of Chinese herbal medicines in the country, more than 80% of the prices of medicinal materials had risen, with an average increase of 109%.
In May of this year, the hype of Chinese herbal medicines was almost a height. At that time, the withdrawal of funds from coal and the stock market was idle, and some businessmen found that hoarding and reselling Chinese herbal medicines could earn high profits, and large sums of money went into the Chinese herbal medicines market. As a result, the gains of 16 Chinese herbal medicines were instantaneously as high as 300%, 31 varieties rose about 180%, and 85 varieties rose between 51% and 100%.
Due to the high prices, pharmaceutical companies lost their production costs, the quality of proprietary Chinese medicines dropped, and even some pharmaceutical companies stopped producing proprietary Chinese medicines, causing panic in the market. However, the same situation as in 2007 occurred in the second half of the year. The increase ended in June 2011 and the price began to behave like a roller coaster. According to the person in charge of the Beijing Traditional Chinese Medicine Association, price fluctuations in October were even more pronounced than in previous months, with 195 varieties showing declines in different ranges, accounting for 36% of the total variety.
With regard to the reason why prices have turned sharply downward, some people in the Chinese herbal medicines market believe that they are affected by the macro-economy, the tight funding, and the weakening of hot money speculation.
Long Xingchao believes that the market is periodically adjusted. Because the prices of Chinese herbal medicines have been continuously rising for several years, a periodic review of the market will inevitably lead to a price correction. In fact, there is another factor. Due to soaring prices of medicinal materials in the past two years, the number of farmers and agriculturists has expanded their planting area. This has led to a significant increase in the number of homegrown medicinal materials. By the fall of 2011, there will be new production of medicinal herbs, and the original inventory of manufacturers will need to be digested. Changes have also contributed to the decline in prices. “Part of the high speculation has returned to rationality, but there is no new distribution of the profit of the drug peasants.†According to the FDA officials, the pharmaceutical companies and drug peasants may also adopt peer-to-peer models in the future. Intermediaries can only earn transportation fees.
The reporter was informed that the State Food and Drug Administration, the Administration of Traditional Chinese Medicine and the National Development and Reform Commission and other departments are planning a support package for Chinese herbal medicines, including organizing the cultivation and excavation of Chinese herbal medicines, establishing a new circulation system, and strengthening supervision of sales links. The new plan will follow the country’s partial policy on agricultural products. It mainly considers the supply and demand balance of Chinese herbal medicines, and plans to build an e-commerce platform to encourage pharmaceutical companies and drug farmers to sell point-to-point, and to prevent hot money speculation.
The TCM official told reporters that through careful and meticulous mediation, the state hopes that the interest of the drug, peasants, pharmaceutical companies, and intermediaries on the interest chain will gradually become more balanced. The above new measures will be implemented next year.
The profit of drug farmers tends to thin
SFDA officials told this newspaper that while the price of Chinese herbal medicines has risen in recent years, the labor costs for planting have also risen. It has become an indisputable fact that the profits of drug farmers have become thinner and thinner.
Taking "Safflower" as an example, at present, a kilogram of land can produce 10 kilograms of safflower. The picking fee for a kilogram of safflower needs 60 yuan, the price for selling to middlemen is the highest when it is 83 kilograms per kilogram. It is 23 yuan, which means that the spread for 10 kg is 230 yuan.
But this 230 yuan also includes various expenses. "Before 2000, a kilogram of picking fee was 8 yuan. At that time, it was very easy to find workers. Now that it has risen to 60 yuan, it is still difficult to find workers." According to the introduction of Chen, a farmer and grower, the safflower was matured for four months. From the start of sowing, he asked the picking workers. After contacting the workers, they had to drive to the home to pick them up. After picking the park, they were arranged separately. After eating and staying, after the picking is completed, the workers have to buy a ticket for the return journey. “Before it was the workers who took the initiative to find us, and the tolls were responsible for them. The food and shelter were sometimes self-care for the workers. Now it is people who come to the door asking for work. If they can’t eat well, it’s not enough. Sleeping also requires Simmons mattresses. Workers’ requests can be It was high.†The farmer said that the workers are now unable to afford it. Because, in addition to these costs, there are also utilities for culturing safflower, so it's best to make a profit of 3% more, and sometimes it's done.
It is understood that the cost of planting, excavation, processing, transportation and other aspects of Chinese herbal medicines has been increasing year by year, and the production cost of medicinal materials has been greatly increased. The production cost of Sanqi in Yunnan Province has risen from 10,000 yuan per acre before 2008 to the current level. 30,000 yuan per mu. Picking of safflower, schisandra, wolfberry, etc., hiring costs as high as 80 to 100 yuan a day. In some years, there are situations where safflower and schisandra are not harvested at the time of harvest. “If this situation continues, the farmers will not grow any more. If they are not planted, they will cause panic in the drug market.†Long Xingchao, director of the Chinese Medicine Information Center of the Chinese Medicine Association, told this newspaper.
Price roller coaster
From the 1990s to 2007, domestic prices of Chinese herbal medicines have been unrelenting, and the real fluctuation cycle has started since 2007.
At the beginning of the year, the prices of some domestic production materials and consumer goods continued to rise. In the Chinese herbal medicine market, Angelica first opened up the price increase and led the prices of northwest medicinal herbs such as Codonopsis, Huanghua, Huanghua, Dahuang, and Yinchen. By the second half of the year, the price of most Chinese herbal medicines has been drastically changed and the roller coaster market has appeared.
However, compared to the price trend in the past two years, the 2007 wave of the market is nothing. According to the monitoring data of Chinese herbal medicines, the Taizi ginseng price was only RMB 22.3/kg in January 2007. By June 2011, its price had reached RMB 250/kg, an increase of 1021.08%.
By the end of 2010, of the 537 varieties of Chinese herbal medicines in the country, more than 80% of the prices of medicinal materials had risen, with an average increase of 109%.
In May of this year, the hype of Chinese herbal medicines was almost a height. At that time, the withdrawal of funds from coal and the stock market was idle, and some businessmen found that hoarding and reselling Chinese herbal medicines could earn high profits, and large sums of money went into the Chinese herbal medicines market. As a result, the gains of 16 Chinese herbal medicines were instantaneously as high as 300%, 31 varieties rose about 180%, and 85 varieties rose between 51% and 100%.
Due to the high prices, pharmaceutical companies lost their production costs, the quality of proprietary Chinese medicines dropped, and even some pharmaceutical companies stopped producing proprietary Chinese medicines, causing panic in the market. However, the same situation as in 2007 occurred in the second half of the year. The increase ended in June 2011 and the price began to behave like a roller coaster. According to the person in charge of the Beijing Traditional Chinese Medicine Association, price fluctuations in October were even more pronounced than in previous months, with 195 varieties showing declines in different ranges, accounting for 36% of the total variety.
With regard to the reason why prices have turned sharply downward, some people in the Chinese herbal medicines market believe that they are affected by the macro-economy, the tight funding, and the weakening of hot money speculation.
Long Xingchao believes that the market is periodically adjusted. Because the prices of Chinese herbal medicines have been continuously rising for several years, a periodic review of the market will inevitably lead to a price correction. In fact, there is another factor. Due to soaring prices of medicinal materials in the past two years, the number of farmers and agriculturists has expanded their planting area. This has led to a significant increase in the number of homegrown medicinal materials. By the fall of 2011, there will be new production of medicinal herbs, and the original inventory of manufacturers will need to be digested. Changes have also contributed to the decline in prices. “Part of the high speculation has returned to rationality, but there is no new distribution of the profit of the drug peasants.†According to the FDA officials, the pharmaceutical companies and drug peasants may also adopt peer-to-peer models in the future. Intermediaries can only earn transportation fees.
Operating Lights,Led Operating Light,Operating Room Lamp,Surgical Lamp To Room
NINGBO TECHART MEDICAL EQUIPMENT CO.,LTD , https://www.techartmed.com